Mobile app version of munafa.co.com
Login or Join
 Learn then Earn
stockMarketNEWS

 story : : Moderna’s RSV vaccine gets Breakthrough Therapy status #FinanceUSA #StockMarketNEWS Moderna Inc. MRNA said Monday that the Food and Drug Administration granted the company’s experimental respiratory

@stockMarketNEWS Tue 31 Jan, 2023

Posted in: #FinanceUSA #StockMarketNEWS

: Moderna’s RSV vaccine gets Breakthrough Therapy status #FinanceUSA #StockMarketNEWS
Moderna Inc. MRNA said Monday that the Food and Drug Administration granted the company’s experimental respiratory syncytial virus vaccine a Breakthrough Therapy Designation. Moderna said it plans to apply for approval in the first half of this year. The company’s stock has gained 18.7% over the past year, while the S&P 500 SPX is down 4.3%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme